ScyMed
For physicians, medical residents, and intensive care practitioners requiring rapid access to clinical formulas and structured documentation templates.
Snapshot
Who is ScyMed?
Providing clinical decision support and medical documentation tools for healthcare professionals. Streamlining complex patient computations and EMR workflows at the point of care.
Target audience
Portfolio
Free 5Last updated
MediCalc®
v10.5.0
7mo ago
Publisher DNA
What defines ScyMed?
Publisher DNA
Primary focus
Clinical decision support and medical documentation tools
Scale
studio
Target audience
Physicians, medical residents, and intensive care practitioners requiring rapid access to clinical formulas and structured documentation templates.
Signature Patterns
- •Focus on clinical decision support and medical reference utilities
- •Integration with hospital EMR/EHR environments
- •Mixed monetization model utilizing both free-to-use and paid reference tools
- •Targeting high-acuity clinical environments like ICUs and diagnostic workflows
Portfolio momentum
With only 2 releases in the last 6 months and a majority of the portfolio classified as abandoned, development is limited to maintaining core clinical calculators and documentation systems.
Portfolio
What does ScyMed ship?
Apps
11 apps analysed
Rivals
Who does ScyMed compete with?
The rivals identified
Nemeses(3)
Serves as a broader clinical decision support alternative to the specialized cardiovascular focus of ASCVD Risk.
Both apps target clinical professionals requiring point-of-care tools, but AMBOSS captures the study-to-practice transition while MediCalc® focuses on hospital workflow integration.
Both apps target healthcare professionals for cardiovascular risk assessment. The rival competes by offering a free, multi-algorithm suite that covers broader clinical needs than the single-equation focus of ASCVD Risk.
Contenders(24)
Both apps target healthcare professionals at the point of care, competing for limited screen time during clinical shifts.
5 Minute Clinical Consult acts as a primary care reference tool for clinicians requiring point-of-care support.
Provides a paid alternative for medical calculations that emphasizes rapid input and multi-result output.
Both applications target clinicians with free clinical decision support tools, creating direct competition for point-of-care usage.
Both apps target clinicians with cardiovascular risk assessment tools, creating direct competition for professional utility in clinical settings.
Both tools target clinicians requiring cardiovascular risk assessment algorithms, creating a direct overlap in the professional medical utility category.
Both apps target clinicians for ASCVD risk assessment using the same ACC/AHA Pooled Cohort Equations, creating direct competition for the same professional user base.
Both apps target healthcare professionals requiring point-of-care clinical references, with QuickEM providing a broader emergency medicine library that overlaps with the rhythm analysis focus of EKG-card.
Both apps target healthcare professionals for point-of-care clinical support, creating direct competition for daily utility in medical workflows.
Both apps target medical professionals requiring clinical calculators, creating direct competition for point-of-care utility.
Both apps target healthcare professionals requiring point-of-care clinical data, with MediCalc® providing complex formula computation and Lab Values+ focusing on reference ranges and medical terminology.
Both apps target medical professionals with free tools, competing for screen time during clinical shifts. They overlap in their utility for healthcare providers, though they serve different functional needs.
Both apps target healthcare professionals requiring clinical calculations, with MediCalc® providing broad utility and the rival focusing on specialized cardiopulmonary bypass and ECMO procedures.
Both apps target clinicians for cardiovascular risk assessment, creating direct competition for the same professional user base.
Both apps target the same professional demographic of medical residents and students seeking point-of-care clinical reference tools.
Both apps target cardiovascular risk assessment, but they serve distinct user segments: ASCVD Risk provides clinical tools for professionals, while Cardiac-Risk-Index-Calculator offers educational insights for consumers.
Both apps target the same clinical audience of cardiology professionals for point-of-care reference, creating direct competition for screen time during clinical workflows.
Both apps target clinicians requiring rapid access to standardized medical formulas, with mediCS offering a broader library of scores compared to the focused cardiovascular scope of ASCVD Risk.
Both tools target healthcare professionals needing point-of-care clinical support and utilize a free pricing model, creating direct competition for the same clinical workflow time.
Both applications target cardiovascular risk assessment, creating a direct overlap in utility for users calculating 10-year heart attack probability. ASCVD Risk serves clinical professionals, while Heart Test targets general consumers seeking rapid risk estimation.
Both apps target healthcare professionals for cardiovascular risk assessment, creating direct competition for clinical utility in emergency and primary care settings.
Both apps target healthcare professionals with specialized clinical calculation tools, competing for space on a clinician's device for point-of-care decision support.
Both apps target healthcare professionals for point-of-care clinical decision support, creating direct competition for daily utility in hospital workflows.
Both apps target clinicians with cardiovascular risk assessment tools, creating direct competition for the same professional user base.
Same space(27)
Full Code targets the same medical professional demographic but shifts focus from documentation to accredited clinical training.
CliniCal Calculator provides a paid alternative for users requiring specialized multi-output medical computations.
PMcardio moves beyond the reference utility of EKG-card by providing automated AI-based diagnostic interpretation of 12-lead ECGs.
ECG Academy targets the same clinical education space as EKG-card but expands the scope to include interactive quizzes and ACLS algorithms.
ECG and ACLS Tutor competes for the same student audience by replacing static reference cards with dynamic waveform simulations.
Provides a focused tool for thromboembolic risk assessment in atrial fibrillation, a subset of the broader cardiovascular scope of ASCVD Risk.
epTools provides specialized diagnostic support for electrophysiologists, offering deeper algorithm-based utility than the general reference cards in EKG-card.
Offers a general-purpose medical calculation tool that competes with the specialized utility of ASCVD Risk.
Provides a specialized risk assessment tool for obstetricians that mirrors the clinical calculation approach of ASCVD Risk.
Functions as an offline clinical calculation tool that avoids the registration requirements found in some professional medical apps.
Eolas Medical provides institutional protocol access to the same clinical audience that uses eH&P™ for note-taking.
Acts as a specialized reference for vascular surgery that includes calculators similar to the clinical tools in ASCVD Risk.
Uses a question-and-answer format to simulate the consultation process, providing a different interaction model than the calculator-based ASCVD Risk.
This app offers clinical reference tools for a specific medical specialty, pediatric care, similar to the nephrology focus of NephroCalc.
Provides a broad medical calculation library that covers cardiology among 50 other specialties.
This tool provides clinical calculation support for veterinary practitioners, serving a parallel professional niche to the human-focused NephroCalc.
This utility addresses the same clinical need for medication safety through automated dosage calculations.
Zomeo serves a niche clinical practitioner audience similar to eH&P™ but focuses on homeopathic case analysis.
Quick Diagnosis & Treatment offers a portable reference guide for the same clinical practitioners using eH&P™.
OpenEvidence functions as a literature-focused search engine for clinical decision support, targeting the same professional user base.
Focuses specifically on cardiovascular risk assessment using WHO tables, directly paralleling the primary function of ASCVD Risk.
Provides evidence-based clinical scores with direct links to supporting literature, serving as a reference for clinicians.
Chartnote Mobile competes by automating the documentation workflow that eH&P™ users perform manually.
ECG-OD Tracker functions as a companion tool for patients to log symptoms during Holter monitoring, whereas EKG-card is a physician-focused reference.
Vera Health provides an AI-driven search alternative for clinicians seeking evidence-based answers during patient care.
Provides a multi-specialty clinical decision support platform that competes with the specialized scope of ASCVD Risk.
ECG Playbook shifts the focus from reference material to conceptual education on the mechanics of ECG creation.
The Analyst's Read
The bottom line on ScyMed
Bottom line
ScyMed maintains a niche position as a provider of specialized clinical utility software for hospital environments. Their long-term viability depends on the continued relevance of their EMR-integrated documentation tools against larger, platform-native clinical systems.
Frequently asked questions
How many apps does ScyMed publish?
What kind of apps does ScyMed make?
What is ScyMed's top app?
What fed this analysis
- Apps analyzed:
- 11
- With full intel:
- 0
- With overview:
- 11
- Website scraped:
- yes
- Social presence:
- no